---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-259691"
form_type: "8-K"
ticker: "LITS"
cik: "0001262104"
company_name: "Lite Strategy, Inc."
filed_at: "2022-10-07T23:59:59+00:00"
generated_at: "2026-06-23T04:38:43.151881+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Director Cheryl Cohen to not stand for reelection at MEI Pharma's 2023 annual meeting

## Summary
- Cheryl L. Cohen informed the board she will not stand for re-election at the fiscal year 2023 annual meeting, effective when her term expires.
- Her decision is not due to any disagreement with the company's operations, policies, or practices.
- Following the meeting and the earlier decision by Dr. White not to stand, the board will be reduced to seven members with no immediate replacement planned.
- The board is considering a successor to the audit committee after the annual meeting; no formal decision made.

## SEC filing metadata
- accession: 0001193125-22-259691
- form_type: 8-K
- ticker: LITS
- cik: 0001262104
- company_name: Lite Strategy, Inc.
- filed_at: 2022-10-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1262104/000119312522259691/0001193125-22-259691-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1262104/000119312522259691/d405808d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-259691
- JSON: https://secwatch.observer/filing/0001193125-22-259691.json
- Plain text: https://secwatch.observer/filing/0001193125-22-259691.txt

## Key facts
- Executive change
  Cheryl L. Cohen departed as Director at Lite Strategy, Inc..
  - Action: decided not to stand for reelection
  - Role: Director
  source text: On October 4, 2022, Cheryl L. Cohen, a member of the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) and member of the Audit Committee of the Board (the “Committee”), informed the Company that she has decided not to stand for reelection at the Company’s fiscal year 2023 annual meeting of stockholders (the “Annual Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1262104/000119312522259691/0001193125-22-259691-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.